亞太金融(08193.HK)出售進匯證券
亞太金融(08193.HK)訂立協議,以200萬元加資產淨值432.14萬元,出售附屬IAM Group。
IAM Group旗下進匯證券為可從事證券及期貨條例項下第一類(證券交易)受規管活動之持牌法團。進匯之主要業務乃證券買賣及投資以及提供證券經紀服務。
公司指,經考慮香港經濟前景不穩定及評估集團之現時業務,董事認為,在並無重大營運資金投入下,其將難以達致目標集團增長,故出售事項為集團提供良機以精簡集團架構,繼而進一步提升集團財務狀況及更好運用集團財務資源,擬將出售事項之所得款項淨額用作集團一般營運資金。
公司預期錄出售虧損30萬元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.